AQR CAPITAL MANAGEMENT LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$271,529

-$40,883 QoQ

Shares Held

72,408

-30.2% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. ACRS ranks #185 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$271,529	72,408	-30.2%	Shares	Other	2026-05-15
2025-12-31	$312,412	103,792	+197.0%	Shares	Defined	2026-02-17
2025-09-30	$66,407	34,952	-90.9%	Shares	Other	2025-11-14
2024-06-30	$424,793	386,177	-36.9%	Shares	Other	2024-08-14
2024-03-31	$759,133	612,205	+2965.9%	Shares	Defined	2024-05-15
2023-03-31	$161,541	19,968	+39.3%	Shares	Defined	2023-05-15
2022-12-31	$225,792	14,336	+28.4%	Shares	Defined	2023-02-14
2022-09-30	$175,689	11,162	+3.8%	Shares	Defined	2022-11-14
2022-06-30	$150,097	10,752	-0.6%	Shares	Defined	2022-08-15
2022-03-31	$186,467	10,816	-45.7%	Shares	Defined	2022-05-16
2021-12-31	$289,854	19,935	-66.6%	Shares	Defined	2022-02-14
2021-09-30	$1,074,528	59,696	+97.3%	Shares	Defined	2021-11-15
2021-06-30	$531,418	30,263	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.